Buffered Lidocaine Syringes at Brooke Army Medical Center, JBSA Ft. Sam Houston, TX

Amendment / Modification

• The offer due date has been extended from June 10, 2026, to June 24, 2026.

• The "Response Due Date" has been updated.

• Clause 52.212-1 "Instructions to Offerors-Commercial Products and Commercial Services" (Deviation 2026-00038) (Tailored) Feb 2026 has been modified and is now an "Addendum to FAR 52.212-1".

• The deadline for submitting quotes has been extended to June 24, 2026, at 11:00 AM/CT.

• Offerors must hold their quotes firm for at least 90 days from the new due date.

• Quotes must be submitted via email to patrick.a.thielemann.civ@health.mil and christopher.a.gregory11.civ@health.mil.

• Quotes received after the new deadline will be considered untimely and ineligible for award.

• The amendment also clarifies requirements for completing SF1449 (Blocks 17 and 30 A-C), providing proof of compliance with federal and state regulations (Factor 1), and submitting pricing (Factor 2).

Solicitation / RFP / RFQ

This solicitation is for the procurement of Buffered Lidocaine Syringes (1% buffered with 8.4% sodium Bicarbonate, 10ml/syringe). The items will be ordered on an as-needed basis.

• Product: Buffered Lidocaine Syringes (1% buffered with 8.4% sodium Bicarbonate, 10ml/syringe)

• Product Service Code: 6505

• Quantity: 6,000 units per CLIN (with options for additional quantities).

• Pricing Arrangement: Firm Fixed Price.

• Item Unique Identification: Requirements for unique item identification are detailed, including specific criteria for items costing $5,000 or more, and for items under $5,000 if specified in the schedule or table. This includes serialization, data matrix marking, and reporting requirements.

• Inspection and Acceptance: Inspection and acceptance will be completed by a Government POC at AMC BAMC FSH - MM, 3551 ROGER BROOKE DR, BLDG 3600, JBSA FT SAM HOUSTON, TX 78234-6200.

• Contract Type: Not explicitly stated, but implies a firm-fixed-price arrangement for the supplies.

• Period of Performance:

  • CLIN 0001: 01 Oct 2026 to 30 Sep 2027
  • Option Line Item 1001: 01 Oct 2027 to 30 Sep 2028
  • Option Line Item 2001: 01 Oct 2028 to 30 Sep 2029
  • Option Line Item 3001: 01 Oct 2029 to 30 Sep 2030
  • Option Line Item 4001: 01 Oct 2030 to 30 Sep 2031

• Delivery: FOB Destination. Transportation costs are the contractor's responsibility. Delivery is to AMC BAMC FSH - MM, JBSA FT SAM HOUSTON, TX.

• Solicitation Issue Date: 02 June 2026

• Offer Due Date/Local Time: 10 June 2026, 11:00 AM/CT

• Submission Method: Quotes are due via email to patrick.a.thielemann.civ@health.mil and christopher.a.gregory11.civ@health.mil. Electronic submissions larger than 20MB must be sent in separate emails.

• Evaluation Factors:

  • Factor 1: Compliance with Specifications (Offerors must provide proof of compliance with federal and state regulations. Unacceptable ratings will result in ineligibility for award).
  • Factor 2: Price (Evaluated for reasonableness, balance, and completeness).

• Award Basis: Lowest Price Technically Acceptable (LPTA).

• Quote Firm Period: Offerors must hold their quote firm for at least 90 days from the due date.

• Set-Aside: This acquisition is set aside for Small Business.

• NAICS Code: 325412

• Size Standard: 1300

• Payment: Payment will be made by electronic funds transfer. Contractors must use Wide Area WorkFlow (WAWF) for payment requests and receiving reports.

• Contract Clauses: Numerous FAR and DFARS clauses are incorporated by reference, including those related to System for Award Management (SAM) registration, item unique identification, payment instructions, and evaluation criteria.